Combination of Peginterferon α-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B-an Indian experience

Combination of Peginterferon α-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B-an Indian experience

Introduction: Treatment strategies for chronic hepatitis B (CHB) using either interferon or Lamivudine can achieve sustained response in 30-40 % in HBeAg positive CHB. Retreatment of treatment failure in CHB and treatment of HBeAg negative patients pose major therapeutic challenge. Because of succes...

Full description

Bibliographic Details
Main Authors: Deepak N. Amarapurkar, Nikhil D. Patel
Format: Article
Language:English
Published: Elsevier 2005-01-01
Series:Annals of Hepatology
Subjects:
HBeAg positive hepatitis B infection
HBeAg negative hepatitis B infection
pegylated interferon
combination therapy
treatment failure group
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119320873

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119320873

Similar Items